Human Leukocyte Antigen (HLA) Testing Market in North America report 2028 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Human Leukocyte Antigen (HLA) Testing Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Plasma donation and organ transplantation increasing
5.1.3 Use of HLA testing in diagnostics growing
5.1.4 Awareness of genetic compatibility rising
5.1.5

5.2 Market Opportunities

5.2.1
5.2.2 Expansion of HLA testing applications in autoimmune disease diagnosis and management.
5.2.3 Growth in demand for advanced HLA testing in stem cell and bone marrow transplant procedures.
5.2.4 Increasing adoption of HLA testing in emerging markets with expanding healthcare infrastructure.

5.3 Future Trends

5.3.1
5.3.2 Integration of next-generation sequencing (NGS) for more accurate and comprehensive HLA typing.
5.3.3 Development of point-of-care HLA testing solutions for rapid compatibility assessment.
5.3.4 Advancements in AI-driven data analysis for faster and more reliable HLA matching.

5.4 Impact of Drivers and Restraints

6. North America Human Leukocyte Antigen (HLA) Testing Market Regional Analysis

6.1 North America Human Leukocyte Antigen (HLA) Testing Market Overview

6.2 North America Human Leukocyte Antigen (HLA) Testing Market Revenue 2020-2028 (US$ Million)

6.3 North America Human Leukocyte Antigen (HLA) Testing Market Forecast Analysis

7. North America Human Leukocyte Antigen (HLA) Testing Market Analysis – by Product and service

7.1 Reagents & Consumables

7.1.1 Overview
7.1.2 Reagents & Consumables: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Software & Services

7.3.1 Overview
7.3.2 Software & Services: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Human Leukocyte Antigen (HLA) Testing Market Analysis – by Technology

8.1 Molecular Assay Technologies

8.1.1 Overview
8.1.2 Molecular Assay Technologies: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Non-Molecular Assay Technologies

8.2.1 Overview
8.2.2 Non-Molecular Assay Technologies: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Human Leukocyte Antigen (HLA) Testing Market Analysis – by End User

9.1 Independent Reference Laboratories

9.1.1 Overview
9.1.2 Non-Molecular Assay Technologies: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Hospital and Transplant Centers

9.2.1 Overview
9.2.2 Non-Molecular Assay Technologies: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Human Leukocyte Antigen (HLA) Testing Market – North America Analysis

10.1 North America

10.1.1 North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.1.1.1.2 US: North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.1.1.1.3 US: North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

10.1.1.2 Canada: North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.1.1.2.2 Canada: North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.1.1.2.3 Canada: North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

10.1.1.3 Mexico : North America Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico : North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.1.1.3.2 Mexico : North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.1.1.3.3 Mexico : North America Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Human Leukocyte Antigen (HLA) Testing Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 CareDx

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Illumina, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Bio-Rad Laboratories, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 TBG Diagnostics Limited

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 F. HOFFMANN-LA ROCHE LTD.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Takara Bio Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Luminex Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Omixon Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 The Sequencing Center

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 HistoGenetics LLC

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

13.13 CD Genomics

13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments

13.14 Quintara Biosciences

13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments

13.15 CREATIVE BIOLABS, INC.

13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments

14. Appendix

14.1 About Business Market Insights